The entanglement of DNA damage and pattern recognition receptor signaling.

CGAS-STING DNA damage response DNA repair Inflammasomes Pattern recognition receptors RIG-I/MDA 5

Journal

DNA repair
ISSN: 1568-7856
Titre abrégé: DNA Repair (Amst)
Pays: Netherlands
ID NLM: 101139138

Informations de publication

Date de publication:
15 Nov 2023
Historique:
received: 04 07 2023
revised: 05 10 2023
accepted: 09 11 2023
medline: 22 11 2023
pubmed: 22 11 2023
entrez: 21 11 2023
Statut: aheadofprint

Résumé

Cells are under constant pressure to suppress DNA damage originating from both exogenous and endogenous sources. Cellular responses to DNA damage help to prevent mutagenesis and cell death that arises when DNA damage is either left unrepaired or repaired inaccurately. During the "acute phase" of DNA damage signaling, lesions are recognized, processed, and repaired to restore the primary DNA sequence whilst cell cycle checkpoints delay mitotic progression, cell death and the propagation of errors to daughter cells. Increasingly, there is recognition of a "chronic phase" of DNA damage signaling, exemplified by the secretion of dozens of cytokines days after the inciting damage event. In this review, we focus on the cellular origin of these chronic responses, the molecular pathways that control them and the increasing appreciation for the interconnection between acute and chronic DNA damage responses.

Identifiants

pubmed: 37988925
pii: S1568-7864(23)00149-0
doi: 10.1016/j.dnarep.2023.103595
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103595

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Cindy T Ha (CT)

Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Maha M Tageldein (MM)

Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Shane M Harding (SM)

Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada; Departments of Radiation Oncology and Immunology, University of Toronto, Toronto, ON, Canada. Electronic address: Shane.Harding@uhnresearch.ca.

Classifications MeSH